Home › Stocks › ACET

ACET — ADICET BIO INC

Reported value held$78.94M
Funds holding (latest)175
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)54
Institutional value$34.98M · 5.31M sh
New / Add / Cut / Exit5 / 15 / 16 / 8 · Updated 2026-11-17
Top-5 / Top-10 concentration54.6% / 74.1%
Institutional holdings change Reducing -0.7% (-35.85K sh)
Institutional value change Down -24.3%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingBuy
Analysts covering10
12-month price target$24.00 (+763.3%)
Last price at fetch$2.78
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)+0.00
Revision score (year)+0.00
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -1.91 — -1.82 -1.99 2 +1−1
Mar 2027 -1.53 — -0.97 -2.10 2 +2
Jun 2027 -1.43 — -0.97 -1.88 2 +2
Sep 2027 -1.35 — -0.98 -1.71 2 +1
Dec 2027 -1.22 — -0.67 -1.77 2 +2
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -7.55 — -7.47 -7.62 2 +1−1
Dec 2027 -5.45 — -3.50 -7.39 2 +2
Dec 2028 -2.43 — -2.43 -2.43 1 +1
Dec 2029 -2.26 — -2.26 -2.26 1 +1

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 54 SEC-registered investment managers reported holding ACET (ADICET BIO INC) in their latest 13F filings, with a combined reported value of $34.98M across 5.31M shares. That is -0.7% by share count (-35.85K shares) versus the previous quarter, while reported value moved -24.3%. Ownership is concentrated: the five largest holders account for 54.6% of reported value and the top ten for 74.1%.

Compared with the prior quarter, 5 opened new positions, 15 added to existing stakes, 16 trimmed, 8 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of ADICET BIO INC (ACET) include Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, ranked by reported 13F value among the 175 institutional holders on this page.

ACET is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 54 5.31M $34.98M -0.7%
Q2 2026 56 5.62M $48.53M -11.0%
Q1 2026 50 6.34M $43.21M +1.8%
Q4 2025 48 6.54M $55.06M -91.5%
Q3 2025 55 49.70M $40.27M +0.5%
Q2 2025 50 49.74M $30.35M -4.4%
Q1 2025 54 51.86M $39.02M -4.7%
Q4 2024 60 55.23M $53.13M -2.4%

Over the 8 quarters shown, institutional share counts decreased 90% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (-91.5%).

Top Institutional Holders (Q3 2026) — 25 funds

FundSharesValuePortfolio WeightChange
RA CAPITAL MANAGEMENT, L.P. 932.62K $6.66M 0.07% Hold
ORBIMED ADVISORS LLC 844.79K $6.03M 0.12% Hold
VANGUARD CAPITAL MANAGEMENT LLC 366.22K $2.61M 0.00% Add
Franklin Resources 724.14K $2.24M 0.00% Add
Renaissance Technologies 214.84K $1.53M 0.00% Reduce
Alyeska Investment Group, L.P. 203.80K $1.46M 0.00% Hold
ADAGE CAPITAL PARTNERS GP, L.L.C. 193.12K $1.38M 0.00% Reduce
Schonfeld Strategic Advisors LLC 188.95K $1.35M 0.01% Reduce
Stonepine Capital Management, LLC history 188.20K $1.34M 1.03% Reduce
Carlyle Group Inc. history 184.29K $1.32M 0.02% Hold
UBS Group AG 118.20K $843.93K 0.00% Add
DAFNA Capital Management LLC 93.81K $669.82K 0.14% Hold
Trexquant Investment LP 89.81K $641.26K 0.01% Add
BRIDGEWAY CAPITAL MANAGEMENT, LLC 85.96K $613.75K 0.01% Hold
Geode Capital Management 84.85K $606.16K 0.00% Reduce
Two Sigma Investments 72.92K $520.61K 0.00% Reduce
Marshall Wace 69.23K $494.34K 0.00% Reduce
Rangeley Capital, LLC history 64.00K $456.96K 0.63% Add
Burkehill Global Management, LP 62.50K $446.25K 0.02% Hold
BlackRock Inc 61.02K $435.71K 0.00% Reduce
REGENERON PHARMACEUTICALS, INC. history 60.51K $432.05K 0.24% Hold
VANGUARD FIDUCIARY TRUST CO 50.67K $361.78K 0.00% Hold
Verdad Advisers, LP 47.55K $339.48K 0.36% Add
DIMENSIONAL FUND ADVISORS LP 38.14K $272.31K 0.00% Add
STATE STREET CORP 36.22K $258.62K 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 25 funds

FundSharesValuePortfolio WeightChange
RA CAPITAL MANAGEMENT, L.P. 932.62K $8.06M 0.07% Reduce
ORBIMED ADVISORS LLC 844.79K $7.30M 0.15% Reduce
Franklin Resources 626.57K $5.41M 0.00% Hold
VANGUARD CAPITAL MANAGEMENT LLC 343.23K $2.97M 0.00% Add
ADAGE CAPITAL PARTNERS GP, L.L.C. 274.38K $2.37M 0.00% Hold
Renaissance Technologies 265.94K $2.30M 0.00% Add
Stonepine Capital Management, LLC history 245.52K $2.12M 1.40% Add
Alyeska Investment Group, L.P. 203.80K $1.76M 0.01% Hold
Schonfeld Strategic Advisors LLC 195.51K $1.69M 0.01% New
Carlyle Group Inc. history 184.29K $1.59M 0.02% Hold
NEXTBio Capital Management LP 157.83K $1.36M 0.63% Hold
Two Sigma Investments 96.84K $836.69K 0.00% Add
GEODE CAPITAL MANAGEMENT, LLC 95.63K $826.70K 0.00% New
Geode Capital Management 95.63K $826.70K 0.00% Reduce
DAFNA Capital Management LLC 93.81K $810.54K 0.15% Hold
BRIDGEWAY CAPITAL MANAGEMENT, LLC 85.96K $742.69K 0.01% New
Marshall Wace 79.49K $686.77K 0.00% New
Trexquant Investment LP 78.00K $673.94K 0.01% Add
JANE STREET GROUP, LLC 70.56K $609.65K 0.00% Add
Burkehill Global Management, LP 62.50K $540.00K 0.02% Hold
BlackRock Inc 62.13K $536.77K 0.00% Add
REGENERON PHARMACEUTICALS, INC. history 60.51K $522.82K 0.29% Hold
Rangeley Capital, LLC history 50.89K $439.71K 0.42% Reduce
VANGUARD FIDUCIARY TRUST CO 50.67K $437.79K 0.00% Add
RBF Capital, LLC 38.58K $333.35K 0.01% Hold

Q1 2026 — 25 funds

FundSharesValuePortfolio WeightChange
RA CAPITAL MANAGEMENT, L.P. 1.18M $8.05M 0.09% Add
ORBIMED ADVISORS LLC 1.03M $7.00M 0.14% Hold
Franklin Resources 626.57K $4.27M 0.00% Hold
Citadel Advisors 381.82K $2.60M 0.00% Add
VANGUARD CAPITAL MANAGEMENT LLC 336.52K $2.29M 0.00% New
Woodline Partners LP 313.12K $2.13M 0.01% Reduce
ADAGE CAPITAL PARTNERS GP, L.L.C. 274.38K $1.87M 0.00% Hold
Prosight Management, LP 250.24K $1.70M 0.28% Hold
Renaissance Technologies 232.59K $1.58M 0.00% Reduce
Stonepine Capital Management, LLC history 221.96K $1.51M 0.90% Add
Alyeska Investment Group, L.P. 203.80K $1.39M 0.00% Hold
Carlyle Group Inc. history 184.29K $1.26M 0.01% Hold
NEXTBio Capital Management LP 157.83K $1.07M 0.50% Hold
Geode Capital Management 101.14K $689.04K 0.00% Add
DAFNA Capital Management LLC 93.81K $638.86K 0.15% Hold
Burkehill Global Management, LP 62.50K $425.62K 0.02% Hold
REGENERON PHARMACEUTICALS, INC. history 60.51K $412.08K 0.86% Hold
Rangeley Capital, LLC history 56.00K $381.36K 0.40% Add
ADAR1 Capital Management, LLC 53.83K $366.56K 0.03% Reduce
SUSQUEHANNA INTERNATIONAL GROUP, LLP 52.90K $360.25K 0.00% New
VANGUARD FIDUCIARY TRUST CO 50.33K $342.77K 0.00% New
Trexquant Investment LP 43.67K $297.37K 0.00% New
Two Sigma Investments 43.11K $293.55K 0.00% Reduce
RBF Capital, LLC 38.58K $262.74K 0.01% Hold
UBS Group AG 38.37K $261.29K 0.00% Add

Q4 2025 — 25 funds

FundSharesValuePortfolio WeightChange
ORBIMED ADVISORS LLC 1.03M $8.66M 0.18% Reduce
RA CAPITAL MANAGEMENT, L.P. 948.25K $7.98M 0.08% Reduce
Franklin Resources 626.57K $5.28M 0.00% New
Woodline Partners LP 625.00K $5.26M 0.02% New
Vanguard Group 291.28K $2.45M 0.00% Reduce
ADAGE CAPITAL PARTNERS GP, L.L.C. 274.38K $2.31M 0.00% New
Prosight Management, LP 250.24K $2.11M 0.43% New
Renaissance Technologies 242.94K $2.05M 0.00% Reduce
Goldman Sachs Group 234.51K $1.97M 0.00% Reduce
Stonepine Capital Management, LLC history 220.01K $1.85M 1.43% New
Alyeska Investment Group, L.P. 203.80K $1.72M 0.01% Reduce
Carlyle Group Inc. history 184.29K $1.54M 0.01% Reduce
NEXTBio Capital Management LP 157.83K $1.33M 0.78% New
Two Sigma Investments 144.80K $1.22M 0.00% Reduce
ADAR1 Capital Management, LLC 128.65K $1.08M 0.08% New
TWO SIGMA ADVISERS, LP 111.34K $937.45K 0.00% Reduce
Citadel Advisors 107.81K $907.79K 0.00% Reduce
DAFNA Capital Management LLC 93.81K $789.90K 0.19% New
Geode Capital Management 88.86K $748.27K 0.00% Reduce
Burkehill Global Management, LP 62.50K $526.25K 0.04% New
REGENERON PHARMACEUTICALS, INC. history 60.51K $509.50K 1.51% Reduce
LUMINUS MANAGEMENT LLC 59.56K $501.48K 0.52% New
BRIDGEWAY CAPITAL MANAGEMENT, LLC 56.35K $474.47K 0.01% Reduce
Squarepoint Ops LLC 55.72K $469.19K 0.00% Add
RBF Capital, LLC 38.58K $324.86K 0.02% Reduce

Q3 2025 — 25 funds

FundSharesValuePortfolio WeightChange
ORBIMED ADVISORS LLC 11.45M $9.27M 0.24% Hold
TANG CAPITAL MANAGEMENT LLC 8.22M $6.66M 0.26% Hold
RA CAPITAL MANAGEMENT, L.P. 7.54M $6.11M 0.07% Hold
Goldman Sachs Group 3.75M $3.04M 0.00% Hold
Vanguard Group 3.27M $2.65M 0.00% Hold
Carlyle Group Inc. history 2.95M $2.39M 0.06% Hold
Renaissance Technologies 1.83M $1.48M 0.00% Add
REGENERON PHARMACEUTICALS, INC. history 968.18K $784.42K 0.11% Hold
BRIDGEWAY CAPITAL MANAGEMENT, LLC 901.60K $730.48K 0.02% Hold
Two Sigma Investments 854.57K $692.37K 0.00% Add
TWO SIGMA ADVISERS, LP 780.98K $632.75K 0.00% Add
Geode Capital Management 706.33K $572.44K 0.00% Hold
Alyeska Investment Group, L.P. 655.66K $531.22K 0.00% Hold
RBF Capital, LLC 617.32K $500.15K 0.02% Hold
BlackRock Inc 585.38K $474.27K 0.00% Reduce
Citadel Advisors 583.95K $473.12K 0.00% Add
MILLENNIUM MANAGEMENT LLC 565.95K $458.54K 0.00% Reduce
Millennium Management 565.95K $458.54K 0.00% Reduce
Schonfeld Strategic Advisors LLC 479.11K $388.17K 0.00% Reduce
JOHNSON & JOHNSON history 364.47K $295.30K 0.06% Hold
WEALTHEDGE INVESTMENT ADVISORS, LLC 300.05K $243.10K 0.09% Reduce
BARCLAYS PLC 300.00K $243.06K 0.00% Add
STATE STREET CORP 244.19K $197.84K 0.00% Reduce
JANE STREET GROUP, LLC 186.20K $150.86K 0.00% New
Northern Trust Corp 140.37K $113.73K 0.00% Hold

Q2 2025 — 25 funds

FundSharesValuePortfolio WeightChange
ORBIMED ADVISORS LLC 11.45M $6.98M 0.18% Hold
TANG CAPITAL MANAGEMENT LLC 8.22M $5.02M 0.25% Hold
RA CAPITAL MANAGEMENT, L.P. 7.54M $4.60M 0.08% Hold
Goldman Sachs Group 3.75M $2.29M 0.00% Reduce
Vanguard Group 3.27M $2.00M 0.00% Add
Carlyle Group Inc. history 2.95M $1.80M 0.04% Hold
Schonfeld Strategic Advisors LLC 1.88M $1.15M 0.01% New
Renaissance Technologies 1.15M $703.83K 0.00% Add
REGENERON PHARMACEUTICALS, INC. history 968.18K $590.59K 0.04% Hold
BRIDGEWAY CAPITAL MANAGEMENT, LLC 901.60K $549.98K 0.01% Hold
Geode Capital Management 706.33K $430.98K 0.00% Reduce
Alyeska Investment Group, L.P. 655.66K $399.96K 0.00% Hold
RBF Capital, LLC 617.32K $376.56K 0.02% Hold
BlackRock Inc 599.49K $365.69K 0.00% Reduce
MILLENNIUM MANAGEMENT LLC 592.33K $361.32K 0.00% Reduce
Millennium Management 592.33K $361.32K 0.00% Reduce
TWO SIGMA ADVISERS, LP 566.04K $345.28K 0.00% Reduce
DAFNA Capital Management LLC 540.00K $329.40K 0.09% Reduce
Two Sigma Investments 512.81K $312.81K 0.00% Add
JOHNSON & JOHNSON history 364.47K $228.01K 0.07% Hold
WEALTHEDGE INVESTMENT ADVISORS, LLC 313.11K $191.00K 0.08% Add
LUMINUS MANAGEMENT LLC 289.94K $176.86K 0.05% New
STATE STREET CORP 246.92K $150.62K 0.00% Hold
Fidelity Management & Research (FMR) 244.78K $149.31K 0.00% Reduce
BARCLAYS PLC 150.00K $91.50K 0.00% New

View all 175 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
RA CAPITAL MANAGEMENT, L.P. 932.62K 932.62K 1.18M 948.25K 7.54M 7.54M 7.54M 7.54M 7.54M 7.54M 7.54M — — — — — — — — —
ORBIMED ADVISORS LLC 844.79K 844.79K 1.03M 1.03M 11.45M 11.45M 11.45M 11.45M 11.45M 11.45M 11.45M 8.32M 8.32M — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 366.22K 343.23K 336.52K — — — — — — — — — — — — — — — — —
Franklin Resources 724.14K 626.57K 626.57K 626.57K — — — — — — — — — — — — — — — —
Renaissance Technologies 214.84K 265.94K 232.59K 242.94K 1.83M 1.15M 810.70K 916.50K 1.23M 1.51M 1.05M 766.60K 677.00K 210.40K 315.80K 29.70K — 125.50K — —
Alyeska Investment Group, L.P. 203.80K 203.80K 203.80K 203.80K 655.66K 655.66K 655.66K 655.66K 655.66K 655.66K 655.66K — — — — — — — — —
ADAGE CAPITAL PARTNERS GP, L.L.C. 193.12K 274.38K 274.38K 274.38K — — — — — — — — — — — — — — — —
Schonfeld Strategic Advisors LLC 188.95K 195.51K — — 479.11K 1.88M — — — 29.60K 1.13M 200.10K — — — — — — — —
Stonepine Capital Management, LLC 188.20K 245.52K 221.96K 220.01K — — 508.27K 700.00K 609.45K 609.45K 141.55K — — — — — — — — —
Carlyle Group Inc. 184.29K 184.29K 184.29K 184.29K 2.95M 2.95M 2.95M 2.95M 2.95M 2.95M 2.95M 2.12M 2.12M — — — — — — —
UBS Group AG 118.20K 29.82K 38.37K 3.80K 21.44K 18.51K 64.04K 203.23K 41.60K 160.84K 53.54K 22.58K 4.34K 27 — 117.59K 17.27K — 547 9.88K
DAFNA Capital Management LLC 93.81K 93.81K 93.81K 93.81K — 540.00K 600.00K 600.00K 600.00K 600.00K 600.00K — 797.05K — — — — — — —
Trexquant Investment LP 89.81K 78.00K 43.67K — — — — — — — — — — — — — — — — —
BRIDGEWAY CAPITAL MANAGEMENT, LLC 85.96K 85.96K — 56.35K 901.60K 901.60K 901.60K 1.03M 851.60K 191.30K 129.80K 54.80K 249.20K — — — — — — —
Geode Capital Management 84.85K 95.63K 101.14K 88.86K 706.33K 706.33K 770.70K 767.54K 768.57K 671.00K 1.20M 661.79K 632.95K 632.97K 606.19K 590.16K 538.50K 421.57K 391.83K 308.52K
Two Sigma Investments 72.92K 96.84K 43.11K 144.80K 854.57K 512.81K 494.98K 703.36K 703.42K 631.09K 521.57K 360.73K 225.32K 154.63K — — 14.37K 329.29K 392.80K 703.61K
Marshall Wace 69.23K 79.49K — — 51.73K — — 40.31K 145.20K 35.32K — — 152.51K — 19.57K — 84.55K 32.19K — —
Rangeley Capital, LLC 64.00K 50.89K 56.00K 25.00K 75.00K — — — — — — — — — — — — — — —
Burkehill Global Management, LP 62.50K 62.50K 62.50K 62.50K — — — — — — — — — — — — — — — —
BlackRock Inc 61.02K 62.13K 36.59K 36.59K 585.38K 599.49K 749.07K 811.78K 752.01K — — — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold ACET?

As of 2026-Q3, 54 institutional funds reported holding ACET (ADICET BIO INC) in SEC 13F filings, with a combined reported value of $34.98M.

How many shares of ACET do institutions own?

13F filers reported 5.31M shares of ACET, worth $34.98M in aggregate at the end of 2026-Q3.

Is institutional ownership of ACET rising or falling?

Share counts moved -0.7% versus the prior quarter — distribution.

Who are the top institutional holders of ACET?

The largest 13F holders are Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Commodore Capital LP, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of ADICET BIO INC?

The major shareholders of ADICET BIO INC (ACET) by reported 13F value are Balyasny Asset Management, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Commodore Capital LP, VANGUARD CAPITAL MANAGEMENT LLC, among 175 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own ACET" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/ACET/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →